Metraipolis › archive › dc_6dce004f05e5

Serial analysis of ESR1 mutations in cell-free DNA from hormone receptor-positive, HER2-negative metastatic breast cancer during palliative endocrine therapy — Europe PMC PMID:41568372

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41568372
DOI
10.3389/fonc.2025.1709317
License (as archived)
solo-consultazione
Archived
2026-11-07T00:43:25.873Z
SHA-256 of the archived text
8dc6a74b0450ea94378cf6c9f1942565184432d145168c279ed48c48903bf2a0
Stable URL of this page
https://metraipolis.com/documento/dc_6dce004f05e5

How to cite

Serial analysis of ESR1 mutations in cell-free DNA from hormone receptor-positive, HER2-negative metastatic breast cancer during palliative endocrine therapy — Europe PMC PMID:41568372 — Europe PMC (en), https://europepmc.org/article/MED/41568372 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6dce004f05e5 (Metraipolis archive dc_6dce004f05e5, sha256 8dc6a74b0450ea94378cf6c9f1942565184432d145168c279ed48c48903bf2a0)
BibTeX
@misc{dc6dce004f05e5,
  title = {Serial analysis of ESR1 mutations in cell-free DNA from hormone receptor-positive, HER2-negative metastatic breast cancer during palliative endocrine therapy — Europe PMC PMID:41568372},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41568372},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6dce004f05e5; sha256 8dc6a74b0450ea94378cf6c9f1942565184432d145168c279ed48c48903bf2a0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41568372. Agents can read the archived copy with the MCP tool read_document.